ArticleCancer immunology, immunotherapy : CII2021

Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations.

Ondrej Uher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.